ArticleScientific reports2024

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study.

Serhat Sekmek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.